Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 8.63 GBp
Change Today 0.00 / 0.00%
Volume 0.0
PEBI On Other Exchanges
Symbol
Exchange
London
As of 11:35 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

port erin biopharma investme (PEBI) Snapshot

Open
8.63 GBp
Previous Close
8.63 GBp
Day High
8.63 GBp
Day Low
8.63 GBp
52 Week High
12/30/14 - 14.25 GBp
52 Week Low
05/12/15 - 7.88 GBp
Market Cap
2.9M
Average Volume 10 Days
58.4K
EPS TTM
0.04 GBp
Shares Outstanding
33.9M
EX-Date
--
P/E TM
2.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for PORT ERIN BIOPHARMA INVESTME (PEBI)

Related News

No related news articles were found.

port erin biopharma investme (PEBI) Related Businessweek News

No Related Businessweek News Found

port erin biopharma investme (PEBI) Details

Port Erin Biopharma Investments Limited is a principal investment firm and is based in the United Kingdom.

port erin biopharma investme (PEBI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

port erin biopharma investme (PEBI) Key Developments

Port Erin Biopharma Investments Limited Reports Unaudited Earnings Results for the Six Months Ended December 31, 2014

Port Erin Biopharma Investments Limited reported unaudited earnings results for the six months ended December 31, 2014. For the period, the company reported investment income of £83,835 against £2,340,447 a year ago. Loss from operating activities was £143,388 against profit from operating activities was £1,787,063 a year ago. Loss before taxation was £143,388 against profit before taxation was £1,787,086 a year ago. Loss for the period was £143,338 or 0.42 pence per basic and diluted share against profit for the period was £1,787,086 or 5.28 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £162,037 against £168,752 a year ago. Net asset value per share as at December 31, 2014 was 14.3 pence.

Port Erin Biopharma Investments Limited Reports Audited Earnings Results for the Year Ended June 30, 2014

Port Erin Biopharma Investments Limited reported audited earnings results for the year ended June 30, 2014. For the period, the company's investment income was £2,099,040 against £588,966 a year ago. Profit from operating activities was £1,381,489 against £406,469 a year ago. Profit before taxation was £1,381,475 against £415,158 a year ago. Profit for the period was £1,381,475 against or £0.0408 per basic and diluted share against £415,158 or £0.0125 per basic and diluted share a year ago. Net cash outflow from operating activities was £363,744 against £103,376 a year ago.

Port Erin Biopharma Investments Limited Reports Unaudited Earnings Results for the Six Months Ended December 31, 2013

Port Erin Biopharma Investments Limited reported unaudited earnings results for the six months ended December 31, 2013. For the period, the company reported investment income of £2,340,447 against £72,881 a year ago. Profit from operating activities was £1,787,063 against £4,077 a year ago. Profit before taxation was £1,787,086 against £9,866 a year ago. Profit for the period was £1,787,086 or 5.28 pence per basic and diluted share against £9,866 or 0.03 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £168,752 against £86,329 a year ago. Net asset value per share as at December 31, 2013 was 15.9 pence against 9.5 pence a year ago, an increase of 10.5%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PEBI:LN 8.63 GBp 0.00

PEBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PEBI.
View Industry Companies
 

Industry Analysis

PEBI

Industry Average

Valuation PEBI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales NM Not Meaningful
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PORT ERIN BIOPHARMA INVESTME, please visit www.porterinbiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.